What is David Mertzlufft's NPI number?

David Mertzlufft's National Provider Identifier (NPI) is 1912098906, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is David Mertzlufft's specialty?

David Mertzlufft is listed in the NPPES registry with a primary specialty of Optometrist (Eye and Vision Services Providers).

Where is David Mertzlufft located?

David Mertzlufft's practice location on file with NPPES is 1360 E Venice Ave, Venice, FL 34285-9066.

What is David Mertzlufft's phone number?

The practice phone number listed in the NPPES registry for David Mertzlufft is (941) 488-2020.

Does David Mertzlufft accept Medicare?

David Mertzlufft is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is David Mertzlufft's NPI active?

Yes — David Mertzlufft's NPI (1912098906) is active in the NPPES registry as of the last update on 2022-02-24.

IndividualActiveAccepts Medicare

David Mertzlufft, OD

NPI 1912098906 · Optometrist · Venice, FL

David Mertzlufft, OD is a Optometrist provider in Venice, FL (NPI 1912098906).

Provider details

NPI number: 1912098906
Entity type: Individual
Primary specialty: OptometristEye and Vision Services Providers
Credential: OD
Sex: Male
Sole proprietor: No
License: OPC2452 (FL)

Practice location

1360 E Venice Ave

Venice, FL 34285-9066

Phone: (941) 488-2020

Fax: (941) 484-2200

Street-level locationGet directions

More FL providers

Mailing address

1360 E Venice Ave

Venice, FL 34285-9066

Specialties & taxonomies

OptometristPrimary152W00000XLicense OPC2452 (FL)
Eye and Vision Services Providers

Enrolled with Medicare as Practitioner - Optometry · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(94/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
3,740 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Complete Exam of Visual System92014	1,721	$120
Established Patient Problem Focused Exam of Visual System92012	773	$85
Imaging of Optic Nerve92133	251	$35
Imaging of Retina92134	237	$39
Exam of Visual Field With Extended Testing92083	235	$60
Photography of the Retina92250	227	$35
New Patient Complete Exam of Visual System92004

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Latanoprost	256	81
Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol	200	56
Neomycin/Polymyxin B/Dexamethabrand: Neomycin-Polymyxin-Dexameth	118	94
Timolol Maleate	76	28
Erythromycin Basebrand: Erythromycin	49	39
Fluorometholone	47	16
Prednisolone Acetate	43	27

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$316 across 5 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-09-27
Last updated: 2022-02-24
Certified: 2022-02-24

Frequently asked questions

What is David Mertzlufft's NPI number?: David Mertzlufft's National Provider Identifier (NPI) is 1912098906, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is David Mertzlufft's specialty?: David Mertzlufft is listed in the NPPES registry with a primary specialty of Optometrist (Eye and Vision Services Providers).
Where is David Mertzlufft located?: David Mertzlufft's practice location on file with NPPES is 1360 E Venice Ave, Venice, FL 34285-9066.
What is David Mertzlufft's phone number?: The practice phone number listed in the NPPES registry for David Mertzlufft is (941) 488-2020.
Does David Mertzlufft accept Medicare?: David Mertzlufft is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is David Mertzlufft's NPI active?: Yes — David Mertzlufft's NPI (1912098906) is active in the NPPES registry as of the last update on 2022-02-24.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Complete Exam of Visual System92014	1,721	$120
Established Patient Problem Focused Exam of Visual System92012	773	$85
Imaging of Optic Nerve92133	251	$35
Imaging of Retina92134	237	$39
Exam of Visual Field With Extended Testing92083	235	$60
Photography of the Retina92250	227	$35
New Patient Complete Exam of Visual System92004

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Latanoprost	256	81
Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol	200	56
Neomycin/Polymyxin B/Dexamethabrand: Neomycin-Polymyxin-Dexameth	118	94
Timolol Maleate	76	28
Erythromycin Basebrand: Erythromycin	49	39
Fluorometholone	47	16
Prednisolone Acetate	43	27

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$316 across 5 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments